Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Xiaoyang Li

Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics

scientific article published in March 2018

Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status.

scientific article published on 2 March 2018

Design, synthesis, and biological characterization of tamibarotene analogs as anticancer agents

scientific article published on 25 April 2016

Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent

scientific article published on June 2016

Discovery of N-(2-Aminophenyl)-4-(bis(2-chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor

scientific article published on 30 August 2019

Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies

scientific article published on 03 April 2019

Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously

scientific article published on 07 June 2018

Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity

scientific article published on 14 September 2016

HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.

scientific article

Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy.

scientific article published in September 2016

Progress of HDAC inhibitor panobinostat in the treatment of cancer

scientific article published on June 2014

Paulina is supported by:

About Paulina

Help